Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Change in Cash (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Change in Cash for 3 consecutive years, with $7.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Cash rose 726.25% year-over-year to $7.5 million, compared with a TTM value of $11.7 million through Sep 2025, up 481.43%, and an annual FY2024 reading of $1.6 million, up 1173.64% over the prior year.
  • Change in Cash was $7.5 million for Q3 2025 at SeaStar Medical Holding, up from $1.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $7.5 million in Q3 2025 and bottomed at -$3.8 million in Q2 2024.
  • Average Change in Cash over 3 years is $1.2 million, with a median of $678000.0 recorded in 2023.
  • Peak annual rise in Change in Cash hit 1405.0% in 2024, while the deepest fall reached 439.33% in 2024.
  • Year by year, Change in Cash stood at $103000.0 in 2023, then plummeted by 355.34% to -$263000.0 in 2024, then skyrocketed by 2936.88% to $7.5 million in 2025.
  • Business Quant data shows Change in Cash for ICU at $7.5 million in Q3 2025, $1.0 million in Q2 2025, and $3.5 million in Q1 2025.